References
1. Br J Obstet Gynaecol. 1995 Feb;102(2):169-70.
2. J Matern Fetal Neonatal Med. 2015 May;28(8):954-8.
3. Am J Med Genet A. 2004 Dec 15;131(3):287-98.
4. J Clin Invest. 2016 Aug 1;126(8):2933-40.
5. Hypertension. 2015 Sep;66(3):687-97.
6. Am J Obstet Gynecol. 2016 Jun;214(6):720.e1-720.e17.
7. Birth Defects Res A Clin Mol Teratol. 2005 Nov;73(11):888-96.
8. Reprod Toxicol. 2008 Oct;26(2):175-7.
9. Ann Pharmacother. 2012 Oct;46(10):1419-24.
10. Open Cardiovasc Med J. 2015 Dec 29;9:114-7.
11. J Clin Pharmacol. 1988;28:942.
12. Am J Med. 2013 Sep;126(9):e7-e8.
Mr. Briggs is clinical professor of pharmacy at the University of California, San Francisco, and adjunct professor of pharmacy at the University of Southern California, Los Angeles, and Washington State University, Spokane. He is coauthor of “Drugs in Pregnancy and Lactation,” and coeditor of “Diseases, Complications, and Drug Therapy in Obstetrics.” He has no relevant financial disclosures.